SCHEMBL18719807

SCHEMBL18719807

COc1ccc(/C=N/c2ccc(S(C)(=O)=O)cc2)c(OC)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.58
▸ CA2 P00918 2/20 0.56
▸ CA1 P00915 1/20 0.56
▸ PTGS2 P35354 7/20 0.49
▸ PTGS1 P23219 1/20 0.49
▸ CA12 O43570 1/20 0.49
▸ CA9 Q16790 1/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ CYP1A1 P04798 2/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP1B1 Q16678 2/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ GRIN2D O15399 2/20 0.47
▸ GRIN3B O60391 2/20 0.47
▸ GRIN1 Q05586 2/20 0.47
▸ GRIN2A Q12879 2/20 0.47
▸ GRIN2B Q13224 2/20 0.47
▸ GRIN2C Q14957 2/20 0.47
▸ GRIN3A Q8TCU5 2/20 0.47
▸ AMY1A P0DUB6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18719808 0.89 CA2 (0.60) HPGDCA2CA1PTGS2PTGS1
SCHEMBL12416976 0.88 CA2 (0.73) HPGDCA2CA1PTGS2PTGS1
SCHEMBL5315002 0.79 PTGS2 (0.76) CA2CA1PTGS2PTGS1CA12
SCHEMBL15896224 0.79 CA12 (0.56) HPGDCA2CA1PTGS2PTGS1
SCHEMBL5315004 0.79 PTGS2 (0.76) CA2CA1PTGS2PTGS1CA12
SCHEMBL12416919 0.77 CA2 (0.77) CA2CA1PTGS2PTGS1CA12
SCHEMBL16119635 0.76 MAPT (0.57) HPGDALDH1A1CYP1A1CYP1A2CYP1B1
SCHEMBL12416758 0.74 CA1 (0.57) HPGDCA2CA1ALDH1A1CYP1A2
SCHEMBL12416959 0.73 ACHE (0.55) HPGDCA2CA1PTGS2PTGS1
SCHEMBL2316541 0.73 GRIN2D (0.64) HPGDALDH1A1CYP1A1CYP1A2CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170100414-A1 SMALL MOLECULE EFFLUX PUMP INHIBITORS UNIVERSITY OF ROCHESTER (US) 2017-04-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170100414-A1 SMALL MOLECULE EFFLUX PUMP INHIBITORS ABCB11, ABCB1, ABCC1 HPGD 424/4885CA2 2754/4885CA1 4863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback